Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease.

@article{Stasi2003TransdermalEA,
  title={Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease.},
  author={Savino M Di Stasi and Antonella Giannantoni and Giovanni Capelli and Emmanuele A Jannini and Guido Virgili and Luigi Storti and Giuseppe Vespasiani},
  journal={BJU international},
  year={2003},
  volume={91 9},
  pages={
          825-9
        }
}
OBJECTIVE To evaluate the effects of the transdermal electromotive administration of verapamil and dexamethasone on plaque size, penile deviation, pain, erectile function and capacity for vaginal penetration in patients with Peyronie's disease. PATIENTS AND METHODS Forty-nine patients were treated four times weekly for six consecutive weeks. During each session the drug mixture was administered from a receptacle fixed to the skin overlying the plaques, using 2.4 mA pulsed current for 20 min… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 26 CITATIONS

Peyronie’s disease: current therapy

  • Translational andrology and urology
  • 2013
VIEW 3 EXCERPTS
CITES BACKGROUND, RESULTS & METHODS
HIGHLY INFLUENCED

All about Peyronie's disease

  • Asian journal of urology
  • 2015
VIEW 1 EXCERPT
CITES BACKGROUND

Similar Papers

Loading similar papers…